School of Pharmacy - News

Depression and other mental health issues reduce the number of productivity-adjusted life years (PALYs) more than musculoskeletal diseases or cardiovascular diseases.

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

The newly appointed Professor of Practice will build bridges between scholars and students of pharmacy, and business and industry.

The new technology uses the eye's natural mechanism to prevent tear evaporation and maintain moisture on the surface of the eye.

By combining the university's cutting-edge research capabilities with Ferring Ventures SA’s industry expertise, the partnership aims to accelerate the development of new precision medicine, specifically cell therapy treatments.

The new facility specialises in the production of a gene therapy drug for non-muscle invasive bladder cancer.

Professor Markus Forsberg has been appointed Dean of the Faculty of Health Sciences and Professor Marja Laasonen Vice Dean of the Philosophical Faculty for the period 1 January to 31 December 2025.

A combination treatment incorporating three existing drugs – tamsulosin, metoprolol and bromocriptine – slowed disease progression in pre-clinical retinopathy models.

Funding was granted to three new Academy Research Fellows, 11 Academy Projects and one new Clinical Researcher at the University of Eastern Finland.

A new study revealed that dogs can learn to identify concentrations of eucalyptus hydrolate that are clearly below the detection threshold of sophisticated analytical instruments used today.